Companies

Affimed NV

NASDAQ: AFMD
$0.18
▲ $0.00 (+0.00%) today
Markets closed · 4:55am ET

About AFMD

Affimed NV, a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany. The company is headquartered in Heidelberg, Germany.

AFMD Coverage

Frequently Asked Questions

What does AFMD do?

Affimed NV, a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany. The company is headquartered in Heidelberg, Germany.